Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ChemoCentryx Inc. (CCXI)

30.7   -1.8 (-5.54%) 01-19 08:28
Open: 32.68 Pre. Close: 32.5
High: 32.885 Low: 30.45
Volume: 1,598,602 Market Cap: 2,150M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibitor for the treatment of anti-neutrophil cytoplasmic autoantibody-associated vasculitis; and completed Phase II clinical trial for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy. The company is also developing CCX559, an orally-administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally-administered inhibitor of the chemokine receptor CC9, which has completed Phase I clinical trial or the treatment of inflammatory bowel disease. In addition, it develops CCX587 for the treatment of TH17 driven diseases. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 32.927 - 33.111 33.111 - 33.28
Low: 29.986 - 30.216 30.216 - 30.427
Close: 30.369 - 30.7 30.7 - 31.003

Technical analysis

as of: 2022-01-19 8:19:53 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 42.70     One year: 47.12
Support: Support1: 30.45    Support2: 25.33
Resistance: Resistance1: 36.56    Resistance2: 40.34
Pivot: 35.07
Moving Average: MA(5): 31.91     MA(20): 35.44
MA(100): 30.88     MA(250): 32.01
MACD: MACD(12,26): -1.11     Signal(9): -0.42
Stochastic oscillator: %K(14,3): 7.88     %D(3): 10.78
RSI: RSI(14): 35.25
52-week: High: 70.29  Low: 9.53  Change(%): -52.6
Average Vol(K): 3-Month: 140187  10-Days: 151317

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CCXI has closed above bottom band by 8.3%. Bollinger Bands are 19.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 12 Jan 2022
Is ChemoCentryx Inc (CCXI) Stock Worth a Buy Wednesday? - InvestorsObserver

Wed, 05 Jan 2022
Recent uptick might appease ChemoCentryx, Inc. (NASDAQ:CCXI) institutional owners after losing 32% over the past year - Simply Wall St

Tue, 04 Jan 2022
ChemoCentryx to Present at Two Upcoming Investor Conferences - The Bakersfield Californian

Mon, 15 Nov 2021
ChemoCentryx (CCXI) Gets Positive CHMP Opinion for Tavneos - Entrepreneur

Wed, 10 Nov 2021
ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript - Motley Fool

Sat, 09 Oct 2021
Is ChemoCentryx, Inc. (NASDAQ:CCXI) Trading At A 41% Discount? - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 70
Shares Float (M) 58
% Held by Insiders 17.70
% Held by Institutions 64.82
Shares Short (K) 5,680
Shares Short P. Month (K) 4,920

Stock Financials

EPS -1.740
EPS Est This Year -0.900
EPS Est Next Year -1.360
Book Value (p.s.) 4.520
Profit Margin
Operating Margin -348.58
Return on Assets (ttm) -15.1
Return on Equity (ttm) -33.6
Qtrly Rev. Growth 248.9
Gross Profit (p.s.) -0.185
Sales Per Share 0.489
EBITDA (p.s.) -1.670
Qtrly Earnings Growth
Operating Cash Flow (M) -84
Levered Free Cash Flow (M) -92

Stock Valuations

PE Ratio -17.64
PEG Ratio
Price to Book value 6.79
Price to Sales 62.73
Price to Cash Flow -25.61

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.